BackAchilles Therapeutics Plc Overview

Achilles Therapeutics Plc Accounts Payable

Track Achilles Therapeutics Plc's accounts payable ($4.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$4.25M
↓ 20.63% YoYΔ $-1.10M vs prior year quarter

Peer trimmed avg / median

Loading

Achilles Therapeutics Plc Accounts Payable History

Loading

Achilles Therapeutics Plc vs. peers: Accounts Payable Comparison

Loading

Achilles Therapeutics Plc Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Achilles Therapeutics Plc (ACHL) FAQ

Achilles Therapeutics Plc (ACHL) currently reports a accounts payable of $4.2M as of September 2024. That compares with $5.4M in the prior-year period — down 20.6% year over year. Use the charts on this page to explore Achilles Therapeutics Plc's accounts payable history and peer comparisons.

Achilles Therapeutics Plc's accounts payable decreased from $5.4M to $4.2M — a 20.6% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Achilles Therapeutics Plc reported $4.2M in accounts payable as of September 2024. That compares with $5.4M in the prior-year period — down 20.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $4.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Achilles Therapeutics Plc, and consider following ACHL for alerts when major investors trade the stock.

Achilles Therapeutics Plc is classified in the Healthcare sector. On accounts payable, it currently shows $4.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ACHL with unrelated industries.